Merck Wins EU Approval for ENFLONSIA to Protect Infants from RSV

Merck Wins EU Approval for ENFLONSIA to Protect Infants from RSV

Summary

On April 17, Merck & Co., Inc.

Description

On April 17, Merck & Co., Inc.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage